Quanterix Corp (NAS:QTRX)
$ 12.33 -0.14 (-1.12%) Market Cap: 473.21 Mil Enterprise Value: 215.93 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 70/100

Quanterix Corp at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 08:35PM GMT
Release Date Price: $11.89 (-1.82%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Good afternoon, everybody. Winding it down here. With me today is Masoud Toloue, CEO of Quanterix, and he's going to give a presentation on the company and the current trends.

Masoud Toloue
Quanterix Corporation - President, CEO & Director

Thanks for having us. Of course, excited to be here. So before we begin, I just want to point to the -- our safe harbor statement. We have, for any forward-looking statements or any GAAP to non-GAAP reconciliations, you can take a look at the statement we have here. You i can also find it on our website.

So we're at a very exciting time in the history of the company, and I would say in the tools and diagnostics market in general. So number before -- are there a great number of discoveries happening in the protein signature space and the conversion of those signatures into biomarkers. And that really goes to the mission at Quanterix. We have an ultra-sensitive detection method for converting protein signatures into biomarkers, which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot